Steroid-Withdrawal at 3 Days After Renal Transplantation with Anti-IL-2 Receptor alpha Therapy: A Prospective, Randomized, Multicenter Study-Reference-Cited by-同舟云学术

Steroid-Withdrawal at 3 Days After Renal Transplantation with Anti-IL-2 Receptor alpha Therapy: A Prospective, Randomized, Multicenter Study

Published:2004-05 Issue:5 Volume:4 Page:803-810
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Meulen Cornelis G. ter,Riemsdijk Iza van,Hene Ronald J.,Christiaans Maarten H. L.,Borm George F.,Gelder Teun van,Hilbrands Luuk B.,Weimar Willem,Hoitsma Andries J.

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-6143.2004.00419.x/fullpdf

Reference36 articles.

1. Incidence and long-term cost of steroid-related side effects after renal transplantation

2. DOUBLE-BLIND COMPARISON OF TWO CORTICOSTEROID REGIMENS PLUS MYCOPHENOLATE MOFETIL AND CYCLOSPORINE FOR PREVENTION OF ACUTE RENAL ALLOGRAFT REJECTION1

3. EFFECTS OF STEROID WITHDRAWAL ON POSTTRANSPLANT DIABETES MELLITUS IN CYCLOSPORINE-TREATED RENAL TRANSPLANT RECIPIENTS

4. PREDNISONE WITHDRAWAL IN KIDNEY TRANSPLANT RECIPIENTS ON CYCLOSPORINE AND MYCOPHENOLATE MOFETIL-A PROSPECTIVE RANDOMIZED STUDY1,2

5. Withdrawal of Cyclosporine or Prednisone Six Months after Kidney Transplantation in Patients on Triple Drug Therapy: A Randomized, Prospective, Multicenter Study

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fixed low dose versus concentration-controlled initial tacrolimus dosing with reduced target levels in the course after kidney transplantation: results from a prospective randomized controlled non-inferiority trial (Slow & Low study);eClinicalMedicine;2024-01

2. Changes in glucose metabolism among recipients with diabetes 1 year after kidney transplant: a multicenter 1-year prospective study;Frontiers in Endocrinology;2023-06-21

3. Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: Endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and the International Society for Heart and Lung Transplantation;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2022-08

4. Safety and metabolic advantages of steroid withdrawal after 6 months posttransplant in de novo kidney transplantation: A 1‐year prospective cohort study;Immunity, Inflammation and Disease;2021-12-15

5. Mycophenolate mofetil versus azathioprine in kidney transplant recipients on steroid-free, low-dose cyclosporine immunosuppression (ATHENA): A pragmatic randomized trial;PLOS Medicine;2021-06-24